IP Verse

Merck Sharp & Dohme patent opposition analysis

Get complete Patent Opposition Report for Merck Sharp & Dohme

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Merck Sharp & Dohme

Explore patent oppositions filed by Merck Sharp & Dohme against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3597659Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHDec 1, 2023
EP3597216Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofE R SQUIBB & SONSApr 27, 2023
EP3760715Large-Scale Production Of Soluble HyaluronidaseHALOZYMEMay 4, 2022
EP2863895Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISKJan 13, 2022
EP3322731Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBBOct 12, 2021
EP3096785Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens And Uses ThereofPFIZERJun 4, 2021
EP2382228Compositions And Methods Of Treating Inflammatory And Autoimmune DiseasesAMGENMay 26, 2021
EP3002298Anti-Factor Xi Monoclonal Antibodies And Methods Of Use ThereofOREGON HEALTH & SCIENCE UNIVERSITYApr 8, 2020
EP3326641Rna Containing Composition For Treatment Of Tumor DiseasesCUREVACMar 24, 2020
EP2676679Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic CompositionsWYETHOct 2, 2019

Latest patents of Merck Sharp & Dohme opposed by its competitors

Explore Merck Sharp & Dohme's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3165220Nov 13, 2024Pharmaceutical Composition Containing An Anti-Nucleating Agent4
EP3283882Oct 16, 2024Blood-Based Biomarkers Of Tumor Sensitivity To Pd-1 Antagonists2
EP1841493May 29, 2024Applicator For Inserting An Implant2
EP3417905Sep 13, 2023Applicator For Inserting An Implant1
EP3265122May 4, 2022Combination Of A Pd-1 Antagonist And Eribulin For Treating Cancer4
EP2981821Nov 3, 2021Immunohistochemical Assay For Detecting Expression Of Programmed Death Ligand 1 (Pd-L1) In Tumor Tissue1
EP2931301Sep 15, 2021Process For Purifying Insulin And Analogues Thereof1
EP3498734Sep 1, 2021Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer14
EP3391890Aug 25, 2021Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta-Cyclodextrin8
EP2970916Apr 14, 2021Adapted Lepidopteran Insect Cells For The Production Of Recombinant Proteins4

Top competitors of Merck Sharp & Dohme